Quarterly dematerialisation certificate submitted for Jul-Sep 2026
ARISTO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.7 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Aristo Bio-Tech has filed a Regulation 74(5) certificate with NSE for the quarter ended September 30, 2026. The certificate from RTA MUFG Intime confirms that share certificates received for dematerialisation during the quarter were processed, listed on stock exchanges, and the company records updated with depository names as registered owners within SEBI timelines.
Routine procedural compliance filing. Confirms orderly handling of share dematerialisation with no impact on shareholders or stock price.